Health Catalyst
HCAT
154 hedge funds and large institutions have $610M invested in Health Catalyst in 2023 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 56 increasing their positions, 50 reducing their positions, and 26 closing their positions.
12% more repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 50
7% more capital invested
Capital invested by funds: $568M → $610M (+$42.1M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.29% less ownership
Funds ownership: 87.08% → 86.78% (-0.29%)
5% less funds holding
Funds holding: 162 → 154 (-8)
31% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 26
65% less call options, than puts
Call options by funds: $233K | Put options by funds: $663K
Top Buyers
Top Sellers
| 1 |
Millennium Management
New York
|
-$14M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
-$7.55M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
-$6.64M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$5.46M |
| 5 |
Goldman Sachs
New York
|
-$3.63M |
HCAT Hedge Fund Activity: Q2 2023 in Review
154 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Health Catalyst (HCAT) for Q2 2023, worth a combined $610M — up 7.4% from $568M a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of HCAT and 18 opened new positions — a net loss of 8 holders — while 50 trimmed existing stakes and 56 added.
The largest buyer was Point72 Asset Management, adding an estimated $12M. The largest seller was Millennium Management, cutting an estimated $14M.
- 154 institutional investors held Health Catalyst (HCAT) as of Q2 2023, down from 162 in Q1 2023.
- Funds reported $610M of Health Catalyst stock for Q2 2023, up 7.4% quarter-over-quarter.
- 18 funds opened new Health Catalyst positions in Q2 2023 and 26 closed out, a net change of -8 holders.
- The largest Health Catalyst buyer in Q2 2023 was Point72 Asset Management, an estimated $12M added.
- The largest Health Catalyst seller in Q2 2023 was Millennium Management, an estimated $14M sold.
Based on aggregated 13F filings for Q2 2023.